info@inbios.com – InBios International, Inc.

Nov. 15, 2022

By info@inbios.com|2022-11-22T19:52:40+00:00November 22nd, 2022|InBios In the News|

InBios Awarded Funding for Lyme Disease Diagnostic from HHS, Cohen Foundation

0

Aug. 29, 2022

By info@inbios.com|2022-08-29T23:05:13+00:00August 29th, 2022|InBios In the News|

Rapid Antigen Tests Accurately Detect COVID Variants

0

Aug. 26, 2022

By info@inbios.com|2022-08-29T23:02:33+00:00August 29th, 2022|InBios In the News|

Antigen Tests Accurately Detect COVID-19 Variants in Study

0

July 24, 2022

By info@inbios.com|2022-05-18T17:34:07+00:00May 18th, 2022|Conferences|

AACC Annual Meeting, July 24-28, Chicago, IL

0

Jan. 18, 2022

By info@inbios.com|2022-01-19T17:30:17+00:00January 19th, 2022|InBios In the News|

InBios Featured on NBC COVID-19 Update

0

Jan. 2, 2022

By info@inbios.com|2022-01-03T21:52:28+00:00January 3rd, 2022|InBios In the News|

Manufacturers Rush to Ramp Up Rapid COVID Test Production

0

Dec. 23, 2021

By info@inbios.com|2022-01-03T21:49:24+00:00January 3rd, 2022|InBios In the News|

Companies Produce 'Tens of Millions' More Rapid COVID Tests

0

Dec. 22, 2021

By info@inbios.com|2022-01-03T21:33:44+00:00January 3rd, 2022|InBios In the News|

U.S. Testing Struggles to Keep Up with Omicron

0

Nov. 30, 2021

By info@inbios.com|2022-01-03T20:05:56+00:00January 3rd, 2022|InBios In the News|

InBios Receives FDA EUA for Home Use Antigen Test for COVID-19

0

Oct. 28, 2021

By info@inbios.com|2021-11-01T21:20:45+00:00November 1st, 2021|InBios In the News|

InBios Receives FDA EUA for COVID-19 Neutralizing Antibody ELISA

0

About info@inbios.com